Why is research and development in cancer treatment slow?
The development of new cancer treatments is a lengthy and resource-intensive process. Clinical trials, which are essential for testing the efficacy and safety of new treatments, require significant time and funding. Regulatory approvals add another layer of complexity and delay. Furthermore, cancer's heterogeneity means that treatments effective for one type may not work for another, necessitating extensive research and development for each specific type.
